- Needham analyst Ryan MacDonald maintained Phreesia Inc PHR with a Buy and raised the price target from $35 to $40.
- The analyst selected Phreesia as the top Digital Health pick for 2023, adding the stock to the Needham Conviction List.
- The selection of PHR reflected MacDonald's thesis that scaled GTM functions and innovations will contribute to revenue acceleration in both Subscription + Payments and rapidly developing Network Solutions.
- MacDonald saw the potential for $27.5 million in revenue upside to the FY24 consensus from scaling the existing client base and penetrating the Medicare age-in opportunity while additional upside drivers remain in-play.
- With investments complete, revenue upside and expense management create a setup for margin outperformance relative to PHR's FY25 targets.
- As a result, the analyst believes PHR will outperform on the top and bottom lines and view PHR's current multiple as an attractive entry point.
- MacDonald reiterated Buy on Udemy, Inc UDMY with a $17 price target.
- The analyst selected Udemy as the top Ed Tech pick for 2023, adding the stock to the Needham Conviction List.
- The selection factored in the analyst's thesis that, despite macro-related headwinds, the company's growth engine, Udemy Business, can continue to grow well north of 40% in FY23. The new logo growth internationally and wallet share gains within the existing customer base in a tighter budget environment likely to drive consolidation aided the growth.
- Outside of UB, MacDonald believes promising web traffic trends, easing comps, and the potential for rising unemployment will stabilize the consumer segment.
- On the bottom line, UDMY's increased focus on hitting breakeven creates the potential for upward revisions to FY23 adjusted EBITDA. When combining this with a valuation of 1.1x the analyst's FY23 revenue estimate, MacDonald believes UDMY will likely outperform.
- Price Action: PHR shares traded higher by 3.57% at $31.93, and UDMY shares traded higher by 3.94% at $11.08 on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in